CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 48 enrolled
Drug / intervention
ropivacaine, ketorolac , morphine sulfate +2 moredrug
Likely dose
ropivacaine, ketorolac , morphine sulfate 30mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01242644
NCT01242644Phase 2Completed

Comparison of a Pain Pump Versus Injectable Medication for Analgesia in Knee Arthroscopy

University of South Alabama·interventional·Posted Nov 17, 2010·Updated Nov 27, 2020

In Brief

A Phase 2 clinical trial evaluating pain pump containing ropivacaine, saline pain pump with injectable medication, and 1 other intervention for Pain. Completed, enrolled 48 participants.

Detailed Summary

Hypothesis: Ropivacaine, morphine and ketorolac injected after knee arthroscopy is as effective as this solution plus ropivacaine administered intra-articularly for twenty-four hours. Three groups were assigned random patients, each group provided a different method of pain medication in order to determine the effectiveness of each treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 17, 2010
Enrollment StartOct 1, 2006
Primary CompletionOct 1, 2009
Study CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 15.6 years ago

Interventions

pain pump containing ropivacainedevice

30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100mL of ropivacaine (0.5%) administered at 4 mL/hour

saline pain pump with injectable medicationdevice

30mL of ropivacaine(0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected plus a pain pump containing 100-mL of normal saline administered at 4 mL/hour

ropivacaine, ketorolac , morphine sulfatedrug

30mL of ropivacaine (0.5%), 30mg of ketorolac and 8mg of morphine sulfate injected